UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression

Cambiano, V; Lampe, FC; Rodger, AJ; Smith, CJ; Geretti, AM; Lodwick, RK; Holloway, J; ... Phillips, AN; + view all (2010) Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression. HIV MED , 11 (3) 216 - 224. 10.1111/j.1468-1293.2009.00771.x.

Full text not available from this repository.

Abstract

ObjectiveThe aim of the study was to assess whether a simple, routinely available measure of antiretroviral therapy (ART) adherence predicts viral rebound at the next HIV viral load (VL) measurement in virally suppressed patients.MethodsThe analysis was performed on the Royal Free HIV Cohort, London, UK. Each 'drug coverage-viral load episode' (DCVL episode) was defined as a 6-month period immediately prior to a VL <= 50 HIV-1 RNA copies/mL (time-zero), during which the patient had been continuously on HAART, with all measured VLs <= 50 copies/mL. The next VL after time-zero was used to assess whether VL rebound (defined as > 200 copies/mL) had occurred. Drug coverage, our measure of adherence, was calculated as the proportion of days in the 6-month period covered by a valid prescription for at least three antiretroviral drugs.ResultsA total of 376 (2.4%) VL rebounds occurred in 15 660 DCVL episodes among 1632 patients. Drug coverage was 100% for 32% of episodes, 95-99% for 16% of episodes and <= 60% for 10% of episodes. The risk ratio of rebound associated with a 10% increase in drug coverage, adjusted for potential confounding variables, was 0.93 (95% confidence interval 0.88-0.98).ConclusionsAntiretroviral drug coverage assessed at the time of VL measurement in patients with undetectable VL is potentially clinically useful for predicting VL rebound at the next VL measurement.

Type: Article
Title: Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression
DOI: 10.1111/j.1468-1293.2009.00771.x
Keywords: antiretroviral drugs, drug adherence, HIV infection, prescription, viral rebound, DRUG-RESISTANCE MUTATIONS, LESS-THAN 95-PERCENT, VIROLOGICAL RESPONSE, PROTEASE INHIBITORS, CLINIC POPULATION, CELL COUNT, LOAD, OUTCOMES, COHORT, RATES
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Pop Health Sciences > Institute for Global Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Pop Health Sciences > Institute for Global Health > Infection and Population Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Pop Health Sciences > Institute of Epidemiology and Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Pop Health Sciences > Institute of Epidemiology and Health > Primary Care and Population Health
URI: http://discovery.ucl.ac.uk/id/eprint/138501
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item